Literature DB >> 7961858

Interplay between estrogens, progestins, retinoic acid and AP-1 on a single regulatory site in the progesterone receptor gene.

J F Savouret1, M Rauch, G Redeuilh, S Sar, A Chauchereau, K Woodruff, M G Parker, E Milgrom.   

Abstract

Transcriptional regulation of the progesterone receptor gene involves induction by estrogens and down-regulation by progestins, retinoic acid, and AP-1 proteins. We have previously identified an intragenic (+698/+723) estrogen-responsive element present in the progesterone receptor gene, which binds the estradiol receptor and mediates estrogen and 4-OH tamoxifen induction. Progesterone receptor gene expression was equally stimulated by estradiol and 4-OH tamoxifen in the presence of a NH2 terminally deleted estrogen receptor mutant lacking activation function 1, suggesting that activation function 2 was the predominant activation domain. This was confirmed by the lack of activity of an estrogen receptor mutant deleted of activation function 2. Repression by progestins, retinoic acid, and AP-1 was mediated by the same estrogen responsive element although retinoic and progesterone receptors as well as AP-1 proteins did not bind to this element. Repression by these proteins appears to involve different transactivating regions of the estrogen receptor. Repression by retinoic receptors involved only activation function 2 whereas repression by progesterone receptor and AP-1 necessitated both functional domains. Since these proteins act without directly contacting the DNA, it seems likely that repression may be achieved by protein-protein interactions among different domains of the estrogen receptor and/or the transcriptional machinery.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961858

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Mechanisms and significance of nuclear receptor auto- and cross-regulation.

Authors:  Pia Bagamasbad; Robert J Denver
Journal:  Gen Comp Endocrinol       Date:  2010-03-23       Impact factor: 2.822

2.  Differential modulation of transcriptional activity of oestrogen receptors by direct protein-protein interactions with retinoid receptors.

Authors:  M R Song; S K Lee; Y W Seo; H S Choi; J W Lee; M O Lee
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

3.  Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells.

Authors:  Yukun Cui; Airu Niu; Richard Pestell; Rakesh Kumar; Edward M Curran; Yunde Liu; Suzanne A W Fuqua
Journal:  Mol Endocrinol       Date:  2006-04-27

4.  A novel function of the Fe65 neuronal adaptor in estrogen receptor action in breast cancer cells.

Authors:  Yuefeng Sun; Ravi Kasiappan; Jinfu Tang; Panida L Webb; Waise Quarni; Xiaohong Zhang; Wenlong Bai
Journal:  J Biol Chem       Date:  2014-03-11       Impact factor: 5.157

5.  Cripto-1 ablation disrupts alveolar development in the mouse mammary gland through a progesterone receptor-mediated pathway.

Authors:  Malgorzata Klauzinska; David McCurdy; Maria Cristina Rangel; Arun Vaidyanath; Nadia P Castro; Michael M Shen; Monica Gonzales; Daniel Bertolette; Caterina Bianco; Robert Callahan; David S Salomon; Ahmed Raafat
Journal:  Am J Pathol       Date:  2015-10-01       Impact factor: 4.307

6.  Progesterone receptor isoform identification and subcellular localization in endometrial cancer.

Authors:  Kimberly K Leslie; Mary-Pat Stein; Nirmala S Kumar; Donghai Dai; Janet Stephens; Angela Wandinger-Ness; Deborah H Glueck
Journal:  Gynecol Oncol       Date:  2005-01       Impact factor: 5.482

7.  Effects of the expression of leptin and leptin receptor (OBR) on the prognosis of early-stage breast cancers.

Authors:  Yongnam Kim; Si-Young Kim; Jae Jin Lee; Jeongho Seo; Youn-Wha Kim; Suck Hwan Koh; Hwi-Joong Yoon; Kyung Sam Cho
Journal:  Cancer Res Treat       Date:  2006-06-30       Impact factor: 4.679

8.  The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.

Authors:  Erin C Ward; Anna V Hoekstra; Leen J Blok; P Hanifi-Moghaddam; John R Lurain; Diljeet K Singh; Barbara M Buttin; Julian C Schink; J Julie Kim
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

Review 9.  Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways.

Authors:  Stephen Safe; Kyounghyun Kim; Kyoungkim Kim
Journal:  J Mol Endocrinol       Date:  2008-09-04       Impact factor: 5.098

Review 10.  The estrogen receptor joins other cancer biomarkers as a predictor of outcome.

Authors:  Kimberly K Leslie; Kristina W Thiel; Henry D Reyes; Shujie Yang; Yuping Zhang; Matthew J Carlson; Nirmala S Kumar; Donghai D Dai
Journal:  Obstet Gynecol Int       Date:  2013-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.